MoneyWorks4Me

Ajanta Pharma - Quaterly Results

28 Jul 2025 Evaluate
A fair growth of 12.19% in the revenue at Rs. 12085.60 millions was reported in the June 2025 quarter as compared to Rs. 10772.70 millions during year-ago period.The Company has registered profit of Rs. 2549.70  millions for the quarter ended June 2025, a growth of 8.02%  over Rs. 2360.30 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 3700.30 millions from 3442.00 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 12085.60 10772.70 12.19 12085.60 10772.70 12.19 43220.40 39711.20 8.84
Other Income 406.30 283.70 43.21 406.30 283.70 43.21 1198.70 1164.80 2.91
PBIDT 3700.30 3442.00 7.50 3700.30 3442.00 7.50 13245.90 12359.10 7.18
Interest 7.30 7.20 1.39 7.30 7.20 1.39 46.00 68.00 -32.35
PBDT 3693.00 3434.80 7.52 3693.00 3434.80 7.52 13199.90 12291.10 7.39
Depreciation 403.10 329.20 22.45 403.10 329.20 22.45 1399.30 1321.60 5.88
PBT 3289.90 3105.60 5.93 3289.90 3105.60 5.93 11800.60 10969.50 7.58
TAX 740.20 745.30 -0.68 740.20 745.30 -0.68 2631.70 2897.10 -9.16
Deferred Tax 32.90 31.10 5.79 32.90 31.10 5.79 51.40 121.30 -57.63
PAT 2549.70 2360.30 8.02 2549.70 2360.30 8.02 9168.90 8072.40 13.58
Equity 250.70 250.70 0.00 250.70 250.70 0.00 250.70 252.70 -0.79
PBIDTM(%) 30.62 31.95 -4.17 30.62 31.95 -4.17 30.65 31.12 -1.53
Peers
Company Name CMP
Sun Pharma. Inds. 1859.90
Dr. Reddys Labs. 1173.00
Cipla 1379.10
Lupin 2080.00
Zydus Lifesciences 1136.70
View more..